Inhibikase Therapeutics (IKT) Announces FDA Clinical Hold on IkT-148009 Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. LULU
2. ZS
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Inhibikase Therapeutics (IKT) Announces FDA Clinical Hold on IkT-148009 Programs
(NASDAQ: IKT) Delayed: 2.50 -0.02 (0.79%)
Previous Close $2.52    52 Week High $ 
Open $2.49    52 Week Low $ 
Day High $2.55    P/E N/A 
Day Low $2.48    EPS $ 
Volume 246,963